Clinical Trials Browser

Unknown × INDUSTRY × oregovomab × Clear all

NCT04938583 2023-10-17

Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

Phase 1/2 Unknown

Ovarian Neoplasms